Prostate cancer DNA vaccine - Genvax/University of Southampton

Drug Profile

Prostate cancer DNA vaccine - Genvax/University of Southampton

Alternative Names: Electroporation-delivered DNA vaccine against prostate cancer - Inovio/University of Southampton; GVX-3322

Latest Information Update: 11 May 2010

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator University of Southampton
  • Developer Genvax; University of Southampton
  • Class Cancer vaccines; DNA vaccines; Gene therapies
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Prostate cancer

Most Recent Events

  • 05 Aug 2009 Immunogenicity data from a phase I/II trial in Prostate cancer released by Inovio
  • 18 Dec 2008 Interim immunogenicity & adverse events data from a phase I/II trial in Prostate cancer presented at the DNA Vaccines 2008 Conference (DNA Vaccines-2008)
  • 31 Oct 2005 Phase-I/II clinical trials in Prostate cancer in United Kingdom (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top